These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 8102048)

  • 1. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
    Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
    Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
    Kahn RS; Siever LJ; Gabriel S; Amin F; Stern RG; DuMont K; Apter S; Davidson M
    Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
    Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
    Iqbal N; Asnis GM; Wetzler S; Kahn RS; Kay SR; van Praag HM
    Biol Psychiatry; 1991 Oct; 30(8):770-8. PubMed ID: 1751620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
    Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
    Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin function and treatment response to clozapine in schizophrenic patients.
    Kahn RS; Davidson M; Siever L; Gabriel S; Apter S; Davis KL
    Am J Psychiatry; 1993 Sep; 150(9):1337-42. PubMed ID: 8394651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.
    Maes M; Meltzer HY
    Psychiatry Res; 1996 Oct; 64(3):147-59. PubMed ID: 8944393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
    Krystal JH; Webb E; Cooney N; Kranzler HR; Charney DS
    Arch Gen Psychiatry; 1994 Nov; 51(11):898-911. PubMed ID: 7944878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
    Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Psychopharmacology (Berl); 1987; 92(1):14-24. PubMed ID: 3110824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.
    Sevy S; Brown SL; Wetzler S; Kotler M; Molcho A; Plutchik R; van Praag HM
    Psychiatry Res; 1994 Sep; 53(3):219-29. PubMed ID: 7870844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
    Ghaziuddin N; King CA; Welch KB; Zaccagnini J; Weidmer-Mikhail E; Mellow AM; Ghaziuddin M; Greden JF
    Psychiatry Res; 2000 Sep; 95(3):183-94. PubMed ID: 10974357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
    Levitan RD; Kaplan AS; Joffe RT; Levitt AJ; Brown GM
    Arch Gen Psychiatry; 1997 Jun; 54(6):521-7. PubMed ID: 9193192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
    Lindenmayer JP; Adityanjee ; Vital-Herne M; Bark N; Grochowski S; Moynihan N
    Biol Psychiatry; 1997 Jul; 42(1):6-12. PubMed ID: 9193736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.
    Seibyl JP; Krystal JH; Price LH; Woods SW; D'Amico C; Heninger GR; Charney DS
    Psychiatry Res; 1991 Sep; 38(3):227-36. PubMed ID: 1754635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.
    Lawlor BA; Sunderland T; Mellow AM; Hill JL; Molchan SE; Murphy DL
    Arch Gen Psychiatry; 1989 Jun; 46(6):542-9. PubMed ID: 2730278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
    Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
    Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys.
    Aloi JA; Insel TR; Mueller EA; Murphy DL
    Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.